Part 1: The mechanism illustration
For the conjugation of cRGD peptides and DOX with Au NS, we first attached GSH onto the surface of Au NS, GSH has both carboxyl and amino groups for further covalent conjugation. Subsequently, cRGD and DOX were immobilized onto Au NS via the covalent bonds with GSH to produce Au-cRGD, Au-DOX, and Au-cRGD-DOX. To track the targeted delivery of Au-RGD in vivo and verify its selective affinity to tumor sites, we also labeled Au-RGD with a hydrophilic indocyanine green (ICG) derivative, MPA to form a NIR fluorescent probe, Au-cRGD-MPA. Upon 765 nm NIR light irradiation, the NIR fluorescence (810 nm) emitted from Au-cRGD-MPA facilitated real time monitoring of the biodistribution of Au-cRGD, especially its tumor-targeting effectiveness in living subjects (Fiure S1A). Figure S1 illustrates the mechanisms of dual therapeutic effects by hyperthermia produced by Au NS upon NIR light irradiation and the anti-cancer drugs loaded on Au NS ( Figure S1 ), the specific binding of Au-cRGD-MPA to integrin α v β 3 ( Figure   S1B )), and the positive tumor-targeting effect of Au-cRGD-DOX via integrin α v β 3 ( Figure S1C) ). Mechanistically, Au-cRGD-DOX first interacts with integrin α v β 3 located on the cell membrane, followed by the receptor mediated endocytosis. After releasing its ligand in the cytoplasm, the integrin α v β 3 recycles to the cell membrane. 
Part 2: Synthesis routine and structures
For the conjugation of cRGD peptides and DOX with Au NS, we first attached GSH onto the surface of Au NS, GSH has both carboxyl and amino groups for further covalent conjugation. Subsequently, cRGD and DOX were immobilized onto Au NS via the covalent bonds with GSH to produce Au-cRGD, Au-DOX, and Au-cRGD-DOX. To track the targeted delivery of Au-RGD in vivo and verify its selective affinity to tumor sites, we also labeled Au-RGD with a hydrophilic indocyanine green (ICG) derivative, MPA to form a NIR fluorescent probe, Au-cRGD-MPA. The Synthesis routine and structures of Au-cRGD-DOX and Au-cRGD-MPA was shown in Figure S2 . 
Part 3: FT-IR spectra
The Fourier transform infrared (FTIR) spectra of Au NS, Au-cRGD-MPA and Au-cRGD-DOX were recordedμ on a FTIR 8400S spectrometer (Shimadzu, Japan).
As shown in Figure S3 , the asymmetrical stretching vibration band at 1190.1 cm-1 and the symmetrical stretching vibration at 1034.9 cm-1 belong to S=O and the stretching vibration band at 637.0 cm -1 belongs to S-O, both attributable to the sulfoacid group of the capping agent, HEPES. The characteristic stretching and bending vibrations arising from the formation of amide bonds used to link Au NS with the conjugated ligands can be assigned as amide I: 1640.3 cm -1 ( Figure S3B ), 1638.1 cm -1 ( Figure S3C ) and amide II: 1563.1 cm -1 , 1560.1 cm -1 ( Figure S3B ). In addition, the bands 1184.0 cm -1 and 1045.0 cm -1 observed in the spectrum of Au-cRGD-MPA could be attributed to S=O stretching vibration of the sulfoacid group in MPA and could be used to differentiate Au-cRGD-MPA from Au-cRGD-DOX given that the characteristic sulfoacid band of Au NS disappeared after modification of DOX. Each well was replaced and the cells were washed three times with PBS (pH 7.0) before addition of 20 µL of MTT solution (5.0 μg/mL). After incubating another 4 h, the medium containing MTT was carefully removed from each well and DMSO (150 µL) was added to each well to dissolve the purple crystals. The plates were gently shaken for 10 min at room temperature before measuring the absorbance at 580 nm.
All test samples were assayed in quadruplicate and the cell viability was calculated using the following formula: Cell viability = (Mean absorbance of test wells -Mean absorbance of medium control wells) / (Mean absorbance of untreated wells -Mean absorbance of medium control well) ×100%.
Determination of the cytotoxicity effects of Au-cRGD-MPA is a crucial criterion for its in vivo applicable. Therefore, we used MTT assay to determine this parameter in MDA-MB-231, Bel-7402 and MCF-7 cancer cells. The probe did not show significant cytotoxicity at concentrations up to 12.5 µM, with more than 80 % of the cells retaining viability after 24 h of treatment with 12.5 μM of Au NS, Au-MPA, or Au-cRGD-MPA ( Figure S4 ). Interestingly, Au-cRGD-MPA maintained slightly higher cell viability than cells treated Au NS and Au-MPA. The observed low cytotoxicity could be attributed to several factors, including the non-toxic nature of the HEPES solution used in the particles formulation and the use of MPA, which is a derivative of indocyanine green (ICG) approved for human use. Moreover, the cell viability for some groups was larger than 100 %, which was impacted by the strong absorbance of Au NS. To further confirm the low toxicity of Au NS based nano-probes, the morphology of the cells including MDA-MB-231, Bel-7402 and MCF-7 cancer cells after treating with Au NS based nanostructures was investigated by visual inspection using optical microscopy. The results indicated that no obvious morphology change was observed for these cell lines. These issues suggest that Au-cRGD-MPA could be a safe nanoprobe for clinical application. 
Part 5: Therapy evaluation of Au-cRGD-DOX in tumor-bearing mice
Tumors of the mice that received the photothermal and chemo-therapy from Au-cRGD-DOX via intratumoral or tail vein injection were obviously much smaller than those of other groups ( Figure S5 ). 
